Attorneys:
Douglas Hallward-Driemeier ,
Albert F. Cacozza, Jr.
A Ropes & Gray team recently secured a victory for its client, a major pharmaceutical company, when a Massachusetts federal judge dismissed with prejudice a False Claims Act qui tam suit filed against the company by a former district manager. The suit alleged off-label promotion of two drugs.
U.S. District Judge Nathaniel M. Gorton found that the suit didn’t identify a “single false claim for reimbursement actually presented . . . upon an identified, purportedly off-label use,” and that the remaining allegations were “insufficient to strengthen the inference that a false claim was actually submitted ‘beyond possibility.’”
The Ropes & Gray team included business & securities litigation partner Doug Hallward-Driemeier and life sciences partner Al Cacozza.
U.S. District Judge Nathaniel M. Gorton found that the suit didn’t identify a “single false claim for reimbursement actually presented . . . upon an identified, purportedly off-label use,” and that the remaining allegations were “insufficient to strengthen the inference that a false claim was actually submitted ‘beyond possibility.’”
The Ropes & Gray team included business & securities litigation partner Doug Hallward-Driemeier and life sciences partner Al Cacozza.
Attorneys
Stay Up To Date with Ropes & Gray
Subscribe to Our Podcast
Ropes & Gray attorneys provide timely analysis on legal developments, court decisions and changes in legislation and regulations.
Follow Us on Social
Stay in the loop with all things Ropes & Gray, and find our more about our people, culture, initiatives and everything that’s happening.
Join Our Mailing List
We regularly notify our clients and contacts of significant legal developments, news, webinars and teleconferences that affect their industries.